DOCSLIB.ORG

Feature-Expression Heat Maps 51

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Feature-Expression Heat Maps 51 University of Groningen The Dysregulated Brain Haarman, Bartholomeus Cornelius Maria IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2017 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Haarman, B. C. M. (2017). The Dysregulated Brain: A psychoimmunological approach to bipolar disorder. University of Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 04-10-2021 The Dysregulated Brain A psychoimmunological approach to bipolar disorder B.C.M. Haarman The Dysregulated Brain A psychoimmunological approach to bipolar disorder Illustration cover Alan Flemming Layout Marieke van der Vliet / dit-s.nl Printed by Pumbo.nl The studies described in this thesis were performed at the Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands; and Radiology Morphological Solutions, Berkel en Rodenrijs, The Netherlands. The studies were financially supported by the European Commission EU-FP7-HEALTH-222963 ‘MOODINFLAME’ and ­­ EU-FP7-PEOPLE- 286334 ‘PSYCHAID’. ISBN 978-90-824638-1-1 (printed version) 978-90-824638-2-8 (digital version) © 2017 B.C.M. Haarman. All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or by any information storage and retrieval system, without written permission from the author. The Dysregulated Brain A psychoimmunological approach to bipolar disorder PhD thesis to obtain the degree of PhD at the University of Groningen on the authority of the Rector Magnificus Prof. E. Sterken and in accordance with the decision by the College of Deans. This thesis will be defended in public on 1 March 2017 at 16:15 hours by Bartholomeus Cornelius Maria Haarman born on 7 August 1978 in Raalte Supervisor(s) Prof. W.A. Nolen Prof. H.A. Drexhage Co-supervisor(s) Dr. R.F. Riemersma – Van der Lek Dr. H. Burger Assessment committee Prof. A. Aleman Prof. V. Arolt Prof. J.D. Laman Table of Contents CHAPTER 1 General background 7 PART 1 Peripheral immune system 25 CHAPTER 2 Relationship between clinical features and inflammation related monocyte gene expression in bipolar disorder 27 CHAPTER 3 Feature-expression heat maps 51 CHAPTER 4 Inflammatory monocyte gene expression 67 CHAPTER 5 Does CRP predict outcome in bipolar disorder in regular outpatient care? 81 PART 2 Neuroimmune system 99 CHAPTER 6 PET and SPECT in bipolar disorders 101 CHAPTER 7 Neuroinflammation in bipolar disorder 121 CHAPTER 8 Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder 141 CHAPTER 9 Diffusion tensor imaging in euthymic bipolar disorder 171 CHAPTER 10 Summary and general discussion 195 Dutch summary 223 List of publications 243 Acknowledgements 247 Curriculum vitae 253 CHAPTER 1 General background Bartholomeus C.M. Haarman Adapted from Haarman BCM, Riemersma - Van der Lek RF, Ruhé HG, Groot JC, Nolen WA, Doorduin J. Bipolar Disorders. In: Dierckx RAJO, Otte A, de Vries EFJ, Waarde A, den Boer JA, editors. PET and SPECT in Psychiatry. Heidelberg: Springer Berlin Heidelberg; 2014. p. 223–51. Introduction Bipolar disorder: diagnostic description Bipolar disorder (BD)1 is a mood disorder characterized by episodic pathologic distur- bances in mood: (hypo)manic episodes and depressive episodes which alternate with euthymic periods, i.e. with normal mood. BD has to be distinguished from (unipolar) major depressive disorder (MDD), which is characterized by only depressive episodes. According to DSM-IV, the core criterion of a (hypo)manic episode is the occurrence of a pathologically elated (euphoria), expansive or irritable mood. DSM-5 added increased energy or activity to this list. In addition to these core criteria, there are other symptoms such as inflated self-esteem or grandiosity, decreased need for sleep, being more talkative than usual, flight of ideas, distractibility, increase in goal-directed activity or psychomotor agitation and excessive involvement in plea- surable activities that have a high potential for painful consequences. A depressive episode consists of at least one of the core symptoms: depressed mood and loss of interest or pleasure, completed with symptoms such as sleep problems, psychomotor changes, fatigue or loss of energy, feelings of worthlessness or excessive feelings of guilt, difficulty concentrating or making decisions and recurrent thoughts of death1. Two types of BD are recognized: bipolar I disorder (BD-I) and bipolar II disorder (BD-II), characterized by the occurrence of manic episode(s) or by only hypomanic episode(s), respectively. The difference between manic and hypomanic episodes (and thus between BD-I and BD-II) is that manic episodes are associated with marked impairment in occupational, relational or social functioning, which can lead to hospitalization, while hypomanic episodes do not have this marked impairment and do not lead to hospitalization. When manic and depressive symptoms co-occur (or alternate very quickly) in the same episode, in DSM-IV it is labeled as a mixed episode and in DSM-5 as a bipolar disorder, manic or depressive episode with mixed features. Manic, depressive and mixed episodes can also be complicated by the presence of concurrent psychotic symptoms. Besides the mood symptoms, many patients with BD also show cognitive dysfunctions which may persist during euthymic periods, and which involve disturbances in various domains such as attention, verbal memory and executive functioning2,3. 8 Epidemiology and burden of disease The lifetime prevalence of BD is about 2% across different countries, women being affected as frequently as men4,5. Across the world, the disorder is sixth among all 1 health conditions in terms of causing disability6 with poor clinical and functional 7 8 9 outcome , increased risk for suicidality and significant societal costs . It has been General background calculated that in the United States the average cost per case ranged from $11,720 to $624,785, based on the severity of the illness9. In the European countries societal costs for managing BD are considered to be high as well10–12. Risk factors Established risk factors for BD include history of BD, and interestingly also other psychiatric disorders, in parents or siblings; severe childhood adversities; and excessive alcohol use, although the last two are viewed as triggers rather than causes in the presence of biological vulnerability13,14. A recent systematic review concluded that it is still unclear whether perinatal infection has a role in the etiology of BD15. This is particularly relevant in view of the present thesis. Diagnostic and treatment complications Although the clinical picture seems clear at first glance, making the diagnosis is more complicated in practice. On average, there is a time lag of about 6 years between the first episode and the making of the right diagnosis, and another six years before the start of adequate treatment. This is in most cases partly impeded by the precedence of depressive episodes without obvious (hypo)manic symptoms at the beginning of the disease16. Because antidepressants appear less effective for the treatment of bipolar depressive episodes than for unipolar MDD17, delayed diagnosis often leads to prolonged illness and dysfunction. Current pathophysiological models It is generally accepted that the cause of BD is multifactorial, with multiple genes making someone vulnerable, and with psychological and social factors causing the genes to be expressed. Moreover, somatic factors are assumed to play a role. To unravel the complex interplay between genotype and phenotype researchers have tried to find intermediary processes that are related to both the underlying geno- type and the ultimate phenotype. Over the last 50 years several pathophysiological theories have been proposed for BD. Of these, we will shortly address the monoamine theory, the neuroinflammation theory, the white matter tract integrity disruption theory and the mitochondrial dysfunction theory. 9 Monoamine theory Since the 1960s, after the discovery of the first antipsychotic and antidepressant drugs, the monoamine theory has been the leading pathophysiological theory for various psychiatric disorders, including MDD and BD18–20. Based on the working mechanism of these drugs, disruption of serotonergic
Load more

Recommended publications
  • The Complete Genome Sequence of Mycobacterium Avium Subspecies Paratuberculosis
    The complete genome sequence of Mycobacterium avium subspecies paratuberculosis Lingling Li*†‡, John P. Bannantine‡§, Qing Zhang*†‡, Alongkorn Amonsin*†‡, Barbara J. May*†, David Alt§, Nilanjana Banerji†¶, Sagarika Kanjilal†‡¶, and Vivek Kapur*†‡ʈ *Department of Microbiology, †Biomedical Genomics Center, and ¶Department of Medicine, University of Minnesota, St. Paul, MN 55108; and §National Animal Disease Center, U.S. Department of Agriculture–Agriculture Research Service, Ames, IA 50010 Communicated by Harley W. Moon, Iowa State University, Ames, IA, July 13, 2005 (received for review March 18, 2005) We describe here the complete genome sequence of a common Map and Mav (11–13). Therefore, it is widely recognized that the clone of Mycobacterium avium subspecies paratuberculosis (Map) development of rapid, sensitive, and specific assays to identify strain K-10, the causative agent of Johne’s disease in cattle and infected animals is essential to the formulation of rational other ruminants. The K-10 genome is a single circular chromosome strategies to control the spread of Map. of 4,829,781 base pairs and encodes 4,350 predicted ORFs, 45 As a first step toward elucidating the molecular basis of Map’s tRNAs, and one rRNA operon. In silico analysis identified >3,000 physiology and virulence, and providing a foundation for the genes with homologs to the human pathogen, M. tuberculosis development of the next generation of Map diagnostic tests and (Mtb), and 161 unique genomic regions that encode 39 previously vaccines, we report the complete genome sequence of a common unknown Map genes. Analysis of nucleotide substitution rates clone of Map, strain K-10. with Mtb homologs suggest overall strong selection for a vast majority of these shared mycobacterial genes, with only 68 ORFs Materials and Methods with a synonymous to nonsynonymous substitution ratio of >2.
    [Show full text]
  • Molecular Genetics of Microcephaly Primary Hereditary: an Overview
    brain sciences Review Molecular Genetics of Microcephaly Primary Hereditary: An Overview Nikistratos Siskos † , Electra Stylianopoulou †, Georgios Skavdis and Maria E. Grigoriou * Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece; [email protected] (N.S.); [email protected] (E.S.); [email protected] (G.S.) * Correspondence: [email protected] † Equal contribution. Abstract: MicroCephaly Primary Hereditary (MCPH) is a rare congenital neurodevelopmental disorder characterized by a significant reduction of the occipitofrontal head circumference and mild to moderate mental disability. Patients have small brains, though with overall normal architecture; therefore, studying MCPH can reveal not only the pathological mechanisms leading to this condition, but also the mechanisms operating during normal development. MCPH is genetically heterogeneous, with 27 genes listed so far in the Online Mendelian Inheritance in Man (OMIM) database. In this review, we discuss the role of MCPH proteins and delineate the molecular mechanisms and common pathways in which they participate. Keywords: microcephaly; MCPH; MCPH1–MCPH27; molecular genetics; cell cycle 1. Introduction Citation: Siskos, N.; Stylianopoulou, Microcephaly, from the Greek word µικρoκεϕαλi´α (mikrokephalia), meaning small E.; Skavdis, G.; Grigoriou, M.E. head, is a term used to describe a cranium with reduction of the occipitofrontal head circum- Molecular Genetics of Microcephaly ference equal, or more that teo standard deviations
    [Show full text]
  • The Yin and Yang of Autosomal Recessive Primary Microcephaly Genes: Insights from Neurogenesis and Carcinogenesis
    International Journal of Molecular Sciences Review The Yin and Yang of Autosomal Recessive Primary Microcephaly Genes: Insights from Neurogenesis and Carcinogenesis Xiaokun Zhou 1, Yiqiang Zhi 1, Jurui Yu 1 and Dan Xu 1,2,* 1 College of Biological Science and Engineering, Institute of Life Sciences, Fuzhou University, Fuzhou 350108, China; [email protected] (X.Z.); [email protected] (Y.Z.); [email protected] (J.Y.) 2 Fujian Key Laboratory of Molecular Neurology, Institute of Neuroscience, Fujian Medical University, Fuzhou 350005, China * Correspondence: [email protected]; Tel.: +86-17085937559 Received: 17 December 2019; Accepted: 26 February 2020; Published: 1 March 2020 Abstract: The stem cells of neurogenesis and carcinogenesis share many properties, including proliferative rate, an extensive replicative potential, the potential to generate different cell types of a given tissue, and an ability to independently migrate to a damaged area. This is also evidenced by the common molecular principles regulating key processes associated with cell division and apoptosis. Autosomal recessive primary microcephaly (MCPH) is a neurogenic mitotic disorder that is characterized by decreased brain size and mental retardation. Until now, a total of 25 genes have been identified that are known to be associated with MCPH. The inactivation (yin) of most MCPH genes leads to neurogenesis defects, while the upregulation (yang) of some MCPH genes is associated with different kinds of carcinogenesis. Here, we try to summarize the roles of MCPH genes in these two diseases and explore the underlying mechanisms, which will help us to explore new, attractive approaches to targeting tumor cells that are resistant to the current therapies.
    [Show full text]
  • Allwithnames.Pdf
    Erythrocytes take up oxygen and release carbon dioxide AL1A1 ADH6ADHXADH7 ADH1G ADH1B ADH4 AL1B1 Cyclin E associated events during G1/S transition FRS-mediated FGFR4 signaling ADH1A CP2E1CP2B6 CP2A6 CP2CJCP2C8 CP2AD CP2C9 CP2D6 Pyrimidine salvageKHK TRP channels AL1A3 CP2J2Fanconi Anemia Pathway AL1A2 I23O1KMO Synthesis of bile acids and bile HYESsalts via 27-hydroxycholesterol AADATKYNUT23O Cobalamin (Cbl, vitamin B12) transport and metabolism CP3A5 ARMS-mediated activation Syndecan interactionsCP3A4 CP1A2 Tryptophan catabolism PANK3PANK2 Abacavir metabolism PANK1 Advanced glycosylation endproduct receptor signaling KCNK3 KCNK9 Loss of ALDH2proteins required for interphase microtubule organization from the centrosome XAV939 inhibits tankyrase, stabilizing AXIN Phase 2 - plateau phase KCNK2 Orc1 removal from chromatin Mineralocorticoid biosynthesis S22A6 S22ABS22AC CP26A Truncations of AMER1 destabilize the destruction complex Cytosolic sensorsPurine ribonucleoside of pathogen-associated monophosphate DNA biosynthesis ST1E1 UMPSPYRD CholineCGAT1 catabolism TPST2ST1A1 Separation ofTPH1 Sister Chromatids Methionine INMTsalvage pathway Phase 4 - restingHPPD membrane potential Classical antibody-mediatedKCNJ4 complement activation Phase I - Functionalization of compounds KCNJ2 Cargo recognition for clathrin-mediatedBODG endocytosis ENTP3ENTP1 CP1B1 ADAL ENTP2 CD38 Costimulation by the CD28 family N-glycan trimming in the ER and Calnexin/Calreticulin cycle METK2TPMT BHMT1 PGH1 Metalloprotease DUBs Retrograde neurotrophin signalling DHSO Caspase-mediated
    [Show full text]
  • The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity
    The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Diallo, Alos Burgess. 2021. The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity. Master's thesis, Harvard University Division of Continuing Education. Citable link https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37367694 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA The Development of a Statistical Model to Study How the Deletion of PD-1 Promotes Anti-Tumor Immunity Alos Diallo A Thesis in the Field of Bioinformatics for the Degree of Master of Liberal Arts in Extension Studies Harvard University March 2021 1 2 Copyright 2021 [Alos Diallo] Abstract T-cells are an essential component to the immune system, but they do not act alone and are instead a component in the body’s immune system. PD-1 and its ligands PD-L1 and PD-L2 play an important role in the regulation of T-cells which are incredibly important to the treatment of cancer. Tumors have been able to hijack the PD-1 inhibitory pathway to evade our body’s immune response. PD-1 pathway blockade, therefore, can serve as an important approach for cancer immunotherapy.
    [Show full text]
  • Protein from Sulfolobus Shibatae Sohail A
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by UCL Discovery 1995 Oxford University Press Nucleic Acids Research, 1995, Vol. 23, No. 10 1775-1781 Cloning and functional analysis of the TATA binding protein from Sulfolobus shibatae Sohail A. Qureshi, Peter Baumann, Tracey Rowlands, Bernard Khoo and Stephen P. Jackson* Wellcome/CRC Institute, Tennis Court Road, Cambridge CB2 1 QR, UK and Department of Zoology, Cambridge University, Cambridge, UK Received January 19, 1995; Revised and Accepted March 28, 1995 GenBank accession no. U2341 9 ABSTRACT Eucarya and Bacteria, relatively little work has been conducted on archaeal transcription systems. Over the past few years, Archaea (formerly archaebacteria) comprise a domain however, several lines of evidence have suggested that the of life that is phylogenetically distinct from both transcription systems of Archaea and Eucarya are fundamentally Eucarya and Bacteria. Here we report the cloning of a homologous. Although Archaea possess just one DNA-dependent gene from the Archaeon Sulfolobus shibatae that RNA polymerase, this enzyme consists of -12 subunits and is encodes a protein with strong homology to the TATA therefore similar in its structural complexity to eukaryotic nuclear binding protein (TBP) of eukaryotes. Sulfolobus RNA polymerases (4). In contrast, bacterial RNA polymerases shibatae TBP is, however, almost as diverged from other archaeal TBPs that have been cloned as it is from contain three core subunits (X, e and 'Y, and a tightly associated eukaryotic TBPs. DNA binding studies indicate that a factor (5). Immunochemical and sequence analyses have S.shibatae TBP recognizes TATA-like A-box sequences revealed that the two largest RNA polymerase subunits of that are present upstream of most archaeal genes.
    [Show full text]
  • The Mitotic Apparatus and Kinetochores in Microcephaly and Neurodevelopmental Diseases
    cells Review The Mitotic Apparatus and Kinetochores in Microcephaly and Neurodevelopmental Diseases 1, , 2 1, , Francesca Degrassi * y , Michela Damizia and Patrizia Lavia * y 1 IBPM Institute of Molecular Biology and Pathology, CNR Consiglio Nazionale delle Ricerche, c/o Department of Biology and Biotechnology “Charles Darwin”, Sapienza University of Rome, 00185 Roma, Italy 2 Department of Biology and Biotechnology “Charles Darwin”, Sapienza University of Rome, 00185 Roma, Italy; [email protected] * Correspondence: [email protected] (F.D.); [email protected] (P.L.); Tel.: +39-06-49917517 (F.D.); +39-06-49917536 (P.L.) These authors contributed equally to this work. y Received: 20 November 2019; Accepted: 21 December 2019; Published: 24 December 2019 Abstract: Regulators of mitotic division, when dysfunctional or expressed in a deregulated manner (over- or underexpressed) in somatic cells, cause chromosome instability, which is a predisposing condition to cancer that is associated with unrestricted proliferation. Genes encoding mitotic regulators are growingly implicated in neurodevelopmental diseases. Here, we briefly summarize existing knowledge on how microcephaly-related mitotic genes operate in the control of chromosome segregation during mitosis in somatic cells, with a special focus on the role of kinetochore factors. Then, we review evidence implicating mitotic apparatus- and kinetochore-resident factors in the origin of congenital microcephaly. We discuss data emerging from these works, which suggest a critical role of correct mitotic division in controlling neuronal cell proliferation and shaping the architecture of the central nervous system. Keywords: microcephaly; mitotic apparatus; kinetochore; chromosome segregation; neural progenitors 1. Introduction Regulators of the mitotic apparatus play key roles in orchestrating chromosome segregation.
    [Show full text]
  • Ankhd1 Enhances Polycystic Kidney Disease Development Via Promoting Proliferation and Fibrosis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.04.977017; this version posted March 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Ankhd1 enhances polycystic kidney disease development via promoting proliferation and fibrosis. Foteini Patera1✦, Guillaume M Hautbergue2, Patricia Wilson3, Paul C Evans1, Albert CM 1 1☆ Ong , Maria Fragiadaki . 1 Department of Infection Immunity and Cardiovascular disease, University of Sheffield Medical School, Sheffield, UK. 2Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK. 3 University College London Centre for Nephrology, University College London, London, United Kingdom. ☆Correspondence and requests for materials should be addressed to MF (email: [email protected]) Running title: ANKHD1 is a novel driver of ADPKD -------------------------------------------------------------------------------------------------------------------------------- ABSTRACT Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic kidney disorder resulting in 10% of patients with renal failure. The molecular events responsible for the relentless growth of cysts are not defined. Thus, identification of novel drivers of ADPKD may lead to new therapies. Ankyrin Repeat and Single KH domain-1 (ANKHD1) controls cancer cell proliferation, yet its role in ADPKD is unexplored. Here, we present the first data that identify ANKHD1 as a driver of proliferative growth in cellular and mouse models of ADPKD. Using the first Ankhd1-deficient mice, we demonstrate that Ankhd1 heterozygosity potently reduces cystic growth and fibrosis, in a genetically orthologous mouse model of ADPKD. We performed transcriptome-wide profiling of patient-derived ADPKD cells with and without ANKHD1 siRNA silencing, revealing a major role for ANKHD1 in the control of cell proliferation and matrix remodelling.
    [Show full text]
  • Protein List
    Protein Accession Protein Id Protein Name P11171 41 Protein 4.
    [Show full text]
  • A Physical Map of the Human Genome
    articles A physical map of the human genome The International Human Genome Mapping Consortium* * A partial list of authors appears at the end of this paper. A full list is available as Supplementary Information. ............................................................................................................................................................................................................................................................................ The human genome is by far the largest genome to be sequenced, and its size and complexity present many challenges for sequence assembly. The International Human Genome Sequencing Consortium constructed a map of the whole genome to enable the selection of clones for sequencing and for the accurate assembly of the genome sequence. Here we report the construction of the whole-genome bacterial arti®cial chromosome (BAC) map and its integration with previous landmark maps and information from mapping efforts focused on speci®c chromosomal regions. We also describe the integration of sequence data with the map. The International Human Genome Sequencing Consortium Construction of the whole-genome BAC map (IHGSC) used a hierarchical mapping and sequencing strategy to The pilot phase of the sequencing project began in 1995, at which construct the working draft of the human genome. This clone-based time efforts were renewed to develop clone-based maps covering approach involves generating an overlapping series of clones that speci®c regions of the genome. To construct these regional maps, we covers the entire genome. Each clone is `®ngerprinted' on the basis screened PAC and BAC clones for STS markers, ®ngerprinted the of the pattern of fragments generated by restriction enzyme positive clones, integrated them into the existing maps, and selected digestion1,2. Clones are then selected for shotgun sequencing and the largest, intact clones with minimal overlap for sequencing.
    [Show full text]
  • (Linoleate/Oleate) Stimulates Prodifferentiation Gene Expression to Restore the Epidermal Barrier and Improve Skin Hydration Krzysztof Bojanowski1,2, William R
    ORIGINAL ARTICLE Isosorbide Di-(Linoleate/Oleate) Stimulates Prodifferentiation Gene Expression to Restore the Epidermal Barrier and Improve Skin Hydration Krzysztof Bojanowski1,2, William R. Swindell3, Shyla Cantor4 and Ratan K. Chaudhuri2,5 The breakdown of the epidermal barrier and consequent loss of skin hydration is a feature of skin aging and eczematous dermatitis. Few treatments, however, resolve these underlying processes to provide full symp- tomatic relief. In this study, we evaluated isosorbide di-(linoleate/oleate) (IDL), which was generated by esterifying isosorbide with sunflower fatty acids. Topical effects of IDL in skin were compared with those of ethyl linoleate/oleate, which has previously been shown to improve skin barrier function. Both IDL and ethyl linoleate/oleate downregulated inflammatory gene expression, but IDL more effectively upregulated the expression of genes associated with keratinocyte differentiation (e.g., KRT1, GRHL2, SPRR4). Consistent with this, IDL increased the abundance of epidermal barrier proteins (FLG and involucrin) and prevented cytokine- mediated stratum corneum degradation. IDL also downregulated the expression of unhealthy skin signature genes linked to the loss of epidermal homeostasis and uniquely repressed an IFN-inducible coexpression module activated in multiple skin diseases, including psoriasis. In a double-blind, placebo-controlled trial enrolling females with dry skin, 2% IDL lotion applied over 2 weeks significantly improved skin hydration and decreased transepidermal water loss (NCT04253704). These results demonstrate mechanisms by which IDL improves skin hydration and epidermal barrier function, supporting IDL as an effective intervention for the treatment of xerotic pruritic skin. Journal of Investigative Dermatology (2021) 141, 1416e1427; doi:10.1016/j.jid.2020.09.029 INTRODUCTION treatments and may be combined with topical corticosteroids Skin barrier defects may occur with aging or because of or oral antihistamines (Anderson and Dinulos, 2009; Elias chronic inflammatory skin diseases.
    [Show full text]
  • A Meta-Analysis of the Effects of High-LET Ionizing Radiations in Human Gene Expression
    Supplementary Materials A Meta-Analysis of the Effects of High-LET Ionizing Radiations in Human Gene Expression Table S1. Statistically significant DEGs (Adj. p-value < 0.01) derived from meta-analysis for samples irradiated with high doses of HZE particles, collected 6-24 h post-IR not common with any other meta- analysis group. This meta-analysis group consists of 3 DEG lists obtained from DGEA, using a total of 11 control and 11 irradiated samples [Data Series: E-MTAB-5761 and E-MTAB-5754]. Ensembl ID Gene Symbol Gene Description Up-Regulated Genes ↑ (2425) ENSG00000000938 FGR FGR proto-oncogene, Src family tyrosine kinase ENSG00000001036 FUCA2 alpha-L-fucosidase 2 ENSG00000001084 GCLC glutamate-cysteine ligase catalytic subunit ENSG00000001631 KRIT1 KRIT1 ankyrin repeat containing ENSG00000002079 MYH16 myosin heavy chain 16 pseudogene ENSG00000002587 HS3ST1 heparan sulfate-glucosamine 3-sulfotransferase 1 ENSG00000003056 M6PR mannose-6-phosphate receptor, cation dependent ENSG00000004059 ARF5 ADP ribosylation factor 5 ENSG00000004777 ARHGAP33 Rho GTPase activating protein 33 ENSG00000004799 PDK4 pyruvate dehydrogenase kinase 4 ENSG00000004848 ARX aristaless related homeobox ENSG00000005022 SLC25A5 solute carrier family 25 member 5 ENSG00000005108 THSD7A thrombospondin type 1 domain containing 7A ENSG00000005194 CIAPIN1 cytokine induced apoptosis inhibitor 1 ENSG00000005381 MPO myeloperoxidase ENSG00000005486 RHBDD2 rhomboid domain containing 2 ENSG00000005884 ITGA3 integrin subunit alpha 3 ENSG00000006016 CRLF1 cytokine receptor like
    [Show full text]